Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Cesar Castillo, Inc. v. Actavis Elizabeth, LLC et al
Case Number:
1:17-cv-00078
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Gibson Dunn
- Kasowitz Benson
- Kirkland & Ellis
- Morgan Lewis
- O'Melveny & Myers
- Williams & Connolly
- Wilson Sonsini
Companies
- Allergan PLC
- Avet Pharmaceuticals Inc.
- Endo International PLC
- Par Pharmaceutical Cos. Inc.
- Teva Pharmaceutical Industries Ltd.
- Upsher-Smith Laboratories Inc.
Sectors & Industries:
-
March 10, 2017
End-Payor Actions Consolidated In Propranolol Antitrust Row
A New York federal judge Thursday consolidated two end-payer cases in a proposed class action alleging that drugmakers conspired to jack up the price of generic blood pressure medication propranolol, and rejected a motion for separate trials for cases filed by direct purchasers.
-
February 08, 2017
US Intervenes In Blood Pressure Drug Antitrust Suit
A New York federal judge on Wednesday granted the U.S. government's request to intervene in a proposed class action alleging that drugmakers conspired to substantially jack up the price of generic blood pressure medication propranolol, after the U.S. said the case could interfere with a criminal investigation.
-
January 05, 2017
Mylan, Teva, Others Face Blood Pressure Drug Antitrust Suit
Mylan Inc., Teva Pharmaceuticals USA Inc., Endo International PLC and nine other drugmakers conspired to substantially jack up the price of generic blood pressure medication propranolol, in violation of the Sherman Antitrust Act, a Puerto Rico-based company said in a proposed class action filed on Thursday in New York federal court.